相似文献
1
Obstructive sleep apnea due to oromandibular dystonia and treated with botulinum toxin.
J Clin Sleep Med. 2020 Jul 15;16(7):1209-1212. doi: 10.5664/jcsm.8454.
2
Treatment of oromandibular dystonia with botulinum toxin A improves apnea in a teenager with quadriplegic cerebral palsy: A case report.
J Pediatr Rehabil Med. 2024;17(1):125-129. doi: 10.3233/PRM-220105.
3
Sleep-related adductor laryngeal dystonia causing sleep apnea: a sleep-related breathing disorder diagnosed with sleep endoscopy and treated with botulinum toxin.
Laryngoscope. 2013 Jun;123(6):1560-3. doi: 10.1002/lary.23708. Epub 2013 May 10.
4
[Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
Neurol Neurochir Pol. 2003;37 Suppl 5:55-60.
5
Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Toxins (Basel). 2021 Aug 29;13(9):605. doi: 10.3390/toxins13090605.
6
Treatment of oromandibular dystonia with botulinum toxin.
Laryngoscope. 1991 Nov;101(11):1216-8. doi: 10.1288/00005537-199111000-00010.
7
Laryngeal Botulinum Toxin Injection: Can It Be a Cause of Obstructive Sleep Apnea as an Adverse Effect?
J Voice. 2022 Jan;36(1):119-122. doi: 10.1016/j.jvoice.2020.04.034. Epub 2020 May 30.
8
Oromandibular dystonia: long-term management with botulinum toxin.
Laryngoscope. 2013 Dec;123(12):3078-83. doi: 10.1002/lary.23265. Epub 2013 Oct 5.
9
Systematic review of botulinum toxin treatment for oromandibular dystonia.
Toxicon. 2018 Jun 1;147:96-99. doi: 10.1016/j.toxicon.2018.02.006. Epub 2018 Feb 14.
10
[Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
Arq Neuropsiquiatr. 2003 Sep;61(3A):607-10. doi: 10.1590/s0004-282x2003000400015. Epub 2003 Sep 16.
引用本文的文献
1
The effect of botulinum toxin in the masticatory and constrictor musculature of the pharynx as an option in the treatment of obstructive sleep apnea: a case report.
J Clin Sleep Med. 2025 Feb 1;21(2):431-434. doi: 10.5664/jcsm.11400.
本文引用的文献
1
Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
J Neural Transm (Vienna). 2019 Feb;126(2):141-148. doi: 10.1007/s00702-018-1960-7. Epub 2019 Jan 2.
2
Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
Semin Neurol. 2016 Feb;36(1):84-91. doi: 10.1055/s-0036-1571952. Epub 2016 Feb 11.
3
Sleep-related adductor laryngeal dystonia causing sleep apnea: a sleep-related breathing disorder diagnosed with sleep endoscopy and treated with botulinum toxin.
Laryngoscope. 2013 Jun;123(6):1560-3. doi: 10.1002/lary.23708. Epub 2013 May 10.
4
Obesity, obstructive sleep apnoea and metabolic syndrome.
Respirology. 2012 Feb;17(2):223-36. doi: 10.1111/j.1440-1843.2011.02081.x.
5
Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.
J Clin Sleep Med. 2009 Jun 15;5(3):263-76.
6
Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches.
Proc Am Thorac Soc. 2008 Feb 15;5(2):185-92. doi: 10.1513/pats.200708-137MG.
7
Treatment of habitual snoring with botulinum toxin: a pilot study.
Sleep Breath. 2008 Mar;12(1):63-8. doi: 10.1007/s11325-007-0136-8.
8
Physical findings in the upper airways related to obstructive sleep apnea in men and women.
Acta Otolaryngol. 2007 Jun;127(6):623-30. doi: 10.1080/00016480600987842.
9
Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study.
Arch Intern Med. 2002 Apr 22;162(8):893-900. doi: 10.1001/archinte.162.8.893.
10
Anaesthetic implications of temporomandibular joint disease.
Can J Anaesth. 1992 Jul;39(6):610-6. doi: 10.1007/BF03008329.
Zotero 插件